Henrik Lindman

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment

Hanna Fredholm, Sonja Eaker, Jan Frisell et al. · PLoS ONE · 2009 · 486 citations · Full text

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

Jonas Bergh, Tom Wiklund, Björn Erikstein et al. · The Lancet · 2000 · 342 citations

Breast Oncology, Oncology, High-risk Breast Cancer +7

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [⁶⁸Ga]ABY-025 Affibody PET/CT

Jens Nørkær Sørensen, Irina Velikyan, Dan Sandberg et al. · Theranostics · 2015 · 260 citations · Full text

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the ¹¹¹In-ABY-025 Affibody Molecule

Jens Sørensen, Dan Sandberg, Mattias Sandström et al. · Journal of Nuclear Medicine · 2014 · 257 citations · Full text

Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study

Åsa Boström, Henrik Lindman, C. Swartling et al. · Radiotherapy and Oncology · 2001 · 247 citations

Atopic Dermatitis, Clinical Dermatology, Potent Corticosteroid Cream +4